Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
New Approaches toward Anti-HIV Chemotherapy — De Clercq Erik (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
New Approaches toward Anti-HIV Chemotherapy
Shared by
De Clercq Erik
KU Leuven
New Approaches toward Anti-HIV Chemotherapy
Article
2005
en
Authors
De Clercq Erik
KU Leuven
Abstract
1 min read
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTNew Approaches toward Anti-HIV Chemotherapy‡Erik De ClercqView Author Information Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium Cite this: J. Med. Chem. 2005, 48, 5, 1297–1313Publication Date (Web):February 12, 2005Publication History Received16 August 2004Published online12 February 2005Published inissue 1 March 2005https://pubs.acs.org/doi/10.1021/jm040158khttps://doi.org/10.1021/jm040158kreview-articleACS PublicationsCopyright © 2005 American Chemical SocietyRequest reuse permissionsArticle Views2514Altmetric-Citations203LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Genetics,Infectious diseases,Inhibitors,Peptides and proteins,Viruses Get e-Alerts
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1997
A Methylated Derivative of 5‘-Noraristeromycin
Katherine L. Seley‐Radtke
,
Stewart W. Schneller
,
De Clercq Erik
Article
1995
Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV Infections
De Clercq Erik
Article
2005
New Approaches to Nanofabrication: Molding, Printing, and Other Techniques
Byron D. Gates
,
Qiaobing Xu
,
M. D. Stewart
,
Declan Ryan
,
C. Grant Willson
,
George M M Whitesides
Article
2000
Chiral Synthesis of 4-[1-(2-Deoxy-β-<scp>l</scp>-ribofuranosyl)] Derivatives of 2-Substituted 5-Fluoroaniline: “Cytosine Replacement” Analogues of Deoxy-β-<scp>l</scp>-cytidine
Zhixian Wang
,
Leonard I. Wiebe
,
Jan Balzarini
,
De Clercq Erik
,
Edward E. Knaus
Article
1992
Structure investigation and anti-HIV activities of high-molecular weight ATA polymers
Mark Cushman
,
Pinglang Wang
,
Dominique Schols
,
De Clercq Erik
,
Joseph G. Stowell
Discussion(0)
No comments yet. Be the first to comment.